anayamalik, Author at European Medical Journal - Page 41 of 120

Elexacaftor-Tezacaftor-Ivacaftor Cuts Liver Complications in Cystic Fibrosis

The availability of elexacaftor–tezacaftor–ivacaftor (ETI) has been associated with a marked reduction in cystic fibrosis liver disease (CFLD) progression, according to a nationwide analysis.

When Surgery Becomes Essential in Severe C. difficile

Severe Clostridioides difficile infection (CDI) can progress rapidly to organ failure and sepsis, and while most patients respond to antibiotic therapy, a minority face life-threatening disease that may require surgical intervention.

Real-World Data Show IL-1 Therapy Replacing Corticosteroids in Pericarditis

IL-1 pathway inhibition is increasingly replacing corticosteroids as the preferred second-line treatment for recurrent pericarditis, according to real-world registry data from the RESONANCE study.

Pancreatic Cancer Vaccine Linked to Extended Survival

A Phase I trial of a pancreatic cancer vaccine targeting mutant KRAS has demonstrated durable immune responses and promising survival outcomes in patients with minimal residual disease following standard treatment.

Lewy Body Dementia Hidden by Long-Term Schizophrenia

Lewy body dementia (LBD) can be especially difficult to identify in patients with a long history of psychiatric illness, where overlapping neuropsychiatric and motor symptoms may mask its emergence.

Kefir-Associated Yeast Linked to Patient Health Risks

Candida kefyr, a yeast species historically considered a rare human pathogen, is now being identified as an emerging cause of invasive fungal infections in solid organ transplant recipients, according to a recent case report and literature review.

Back-to-School Spike in Asthma, Who is Hit Hardest?

Children from disadvantaged neighborhoods face a sharper increase in viral-associated asthma exacerbations when returning to school after summer, according to a new population-based analysis.

Ultrasound Pinpoints Key Psoriatic Arthritis Phenotypes

Ultrasound imaging may offer a more precise way to distinguish between inflammatory and non-inflammatory phenotypes in patients with difficult-to-treat psoriatic arthritis (D2T-PsA), according to new multicentre cross-sectional study findings.

Integrative Therapies May Break Atopic Dermatitis Itch Cycle

Chronic pruritus, the hallmark symptom of atopic dermatitis (AD), is driven by a relentless itch–scratch cycle that can persist despite clinical improvements from conventional therapies.

Melanoma–Vitiligo Connection Varies by Ethnicity

A large population-based case–control study has found that a history of malignant melanoma (MM) does not increase the likelihood of developing vitiligo in the general population, with a notable exception in the Arab minority.